{"id":37293,"date":"2025-09-09T23:32:03","date_gmt":"2025-09-09T23:32:03","guid":{"rendered":"https:\/\/usdailys.com\/?p=37293"},"modified":"2025-09-09T23:33:20","modified_gmt":"2025-09-09T23:33:20","slug":"russia-claims-that-new-cancer-vaccine-has-100-efficacy-and-safety-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/usdailys.com\/?p=37293","title":{"rendered":"Russia claims that new cancer vaccine has 100% efficacy and safety in clinical trials"},"content":{"rendered":"
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n

Russia claims that new cancer vaccine has 100% efficacy and safety in clinical trials<\/h1>\n<\/div>\n
Article saved!<\/span>Article saved!<\/span><\/span><\/div>\n<\/section>\n
\n
\n
\n
<\/div>\n

 <\/p>\n

Russia has claimed that they have developed a new vaccine<\/a> that could see cancer cured once and for all.<\/p>\n

Veronika Skvortsova, the head of the Russian Federal Medical-Biological Agency (FMBA), shared the news at the Eastern Economic Forum (EEF) in Vladivostok, per Russian news agency TASS.<\/a><\/p>\n

According to Skvortsova, the research took several years, with the last three years focusing on mandatory preclinical studies.<\/p>\n

She stated: “The vaccine<\/a> is now ready for use; we are awaiting official approval.”<\/p>\n

In addition to reportedly being safe even with repeated administration, the Enteromix vaccine demonstrated significant effectiveness in reducing tumor size and slowing tumor progression.<\/p>\n

These results showed reductions ranging from 60 to 80 percent, depending on the specific disease, with some studies also noting increased survival rates.<\/p>\n

\n
<\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n

Some reports even claim the vaccine achieved 100% efficacy in preclinical trials, although this remains unverified by independent sources.<\/p>\n <\/picture> \"GettyImages-2167929853.jpg\" <\/picture>Russia has claimed that it has cured cancer. (stock image) Credit: THOM LEACH \/ SCIENCE PHOTO LIBRARY \/ Getty<\/em><\/p>\n

The Vaccine\u2019s Focus: Colorectal Cancer and Beyond<\/strong><\/h2>\n

Initially, the Enteromix vaccine targets colorectal cancer<\/a>, but reports suggest that promising progress has been made in developing vaccines for other aggressive cancers such as glioblastoma and specific types of melanoma, including ocular melanoma, per the Times of India.<\/a><\/p>\n

The vaccine, developed using mRNA technology similar to that of Covid-19 vaccines, trains the immune system to recognize and eliminate cancer cells<\/a> while causing fewer side effects than traditional treatments like chemotherapy or radiation.<\/p>\n

Early studies indicated that the vaccine was well-tolerated by patients, with no serious side effects.<\/p>\n

A Personalized Treatment: The Future of Cancer Therapy?<\/strong><\/h2>\n

One of the most intriguing aspects of Enteromix is that it is personalized for each individual patient.<\/p>\n

The vaccine\u2019s ability to target and destroy cancerous tumors while boosting the immune system is being touted as a major step forward in cancer treatment.<\/p>\n

\n
<\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n

It represents a shift away from generic treatments like chemotherapy that often have severe side effects, to a more tailored approach that could improve patient outcomes with fewer risks.<\/p>\n <\/picture> \"GettyImages-1311515350.jpg\" <\/picture>The vaccine is waiting approval. Credit: Javier Zayas Photography \/ Getty<\/em><\/p>\n

Experts Weigh In: Cautious Optimism Amid Limited Data<\/strong><\/h2>\n

While the results have sparked excitement, experts are cautious about jumping to conclusions.<\/p>\n

Dr. David James Pinato, a clinician scientist and medical oncologist at Imperial College London, expressed concerns about the quality of the data released.<\/p>\n

Speaking to Newsweek<\/a>, he explained that preclinical trials, which typically involve testing on animals, are not conclusive proof of a vaccine’s efficacy in humans.<\/p>\n

Pinato noted: \u201cThe fact that a vaccine approach has had 100 percent efficacy in animals means absolutely nothing. This is because very often the immune system of animal models does not replicate the complexity of the cancer genome or the human immune system.\u201d<\/p>\n

He emphasized the need for further testing in human clinical trials to confirm any results before the vaccine could be used clinically.<\/p>\n

\n
<\/div>\n<\/div>\n
\n
<\/div>\n<\/div>\n

\u201cIf this is truly preclinical results, it’s amazing, it’s interesting, but it’s by no means something that can be advocated for clinical use [yet],\u201d he said.<\/p>\n

Enteromix in Clinical Trials: What We Know So Far<\/strong><\/h2>\n

As of now, Enteromix has already entered clinical trials, with 48 volunteers participating in testing.<\/p>\n

The vaccine has demonstrated potential in slowing tumor growth and, in some cases, completely destroying tumors, but it has yet to clear regulatory hurdles.<\/p>\n

According to reports, the vaccine uses harmless viruses to target and destroy cancerous cells while strengthening the body\u2019s immune response.<\/p>\n <\/picture> \"GettyImages-1311515330.jpg\" <\/picture>Some scientists remain sceptical. Credit: Javier Zayas Photography \/ Getty<\/em><\/p>\n

The clinical trials began earlier this year, with the Russian Ministry of Health\u2019s National Medical Research Radiology Centre and the Engelhardt Institute of Molecular Biology collaborating on its development.<\/p>\n

The trials, first announced at the St. Petersburg International Economic Forum, are part of Russia\u2019s larger push to make significant advancements in medical research and biotechnology.<\/p>\n

With preclinical testing completed, the only step remaining before Enteromix can be made available to the public is regulatory approval.<\/p>\n

If it passes, Enteromix could become the first personalized mRNA cancer vaccine available to the general public.<\/p>\n

Featured image credit: THOM LEACH \/ SCIENCE PHOTO LIBRARY \/ Getty<\/h6>\n<\/div>\n<\/div>\n
<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Russia claims that new cancer vaccine has 100% efficacy and safety in clinical trials Article saved!Article saved!   Russia has claimed that they have developed a new vaccine that could … <\/p>\n","protected":false},"author":2,"featured_media":37294,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-37293","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37293"}],"version-history":[{"count":2,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37293\/revisions"}],"predecessor-version":[{"id":37296,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37293\/revisions\/37296"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/media\/37294"}],"wp:attachment":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}